BridgeBio Pharma Inc. (BBIO)

BBIO trades at $51.3, 14.0% above the near-term max pain of $45 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($17.5-$50), signaling increased put positioning or downside protection. Key magnetic zone at 50 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for BBIO shows a downward trend from 50 to 17.5, indicating bearish sentiment or hedging activity. The 87% spread signals divergent expectations across timeframes. Most levels below 51.3 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.